SONN Past Earnings image   This SONN past earnings page last updated 12/19/2022
SONN Past Earnings
PeriodPast Earnings DateGAAP
Q4 202212/15/2022-1.660
Q3 20228/15/2022-1.820
Q2 20225/10/2022-1.960
Q1 20222/8/2022-1.400
Q4 202112/17/2021-1.260
Q3 20218/16/2021-3.780
Q2 20215/17/2021-4.480
Q1 20212/16/2021-4.760
Q4 202012/17/2020-66.220
Q3 20208/14/2020-6.160
Q2 20205/18/2020-0.700
SONN Past Revenue
PeriodPast Earnings DateGAAP
Q4 202212/15/20220.06M
Q3 20228/15/20220.06M
Q2 20225/10/20220.10M
Q1 20222/8/20220.00B
Q4 202112/17/2021NA
Q3 20218/16/2021NA
Q2 20215/17/2021NA
Q1 20212/16/2021NA
Q4 202012/17/2020NA
Q3 20208/14/2020NA
Q2 20205/18/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree SONN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sonnet BioTherapeutics (SONN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SPNE Past Earnings
SPPI Past Earnings
SPRB Past Earnings
SPRO Past Earnings
SQL Past Earnings
SQZ Past Earnings
SRDX Past Earnings
SRGA Past Earnings
SRNE Past Earnings
SRPT Past Earnings

SONN Past Earnings Q&A

What was the best and worst SONN past earnings results?
For Sonnet BioTherapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest SONN past earnings result in our data set was -0.700/share posted in Q2 2020, while the lowest was in Q4 2020 when SONN posted -66.220/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when SONN reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q4 2021 at NA of revenue.

  Suggested answer: There are 11 SONN past earnings results in our data set.

On this page we presented the SONN past earnings date information for Sonnet BioTherapeutics. Reviewing that SONN Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2020, when SONN posted gaap of -0.700/share. Meanwhile the lowest SONN past earnings result was in Q4 2020, when SONN posted gaap of -66.220/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when SONN reported 0.00B in revenue, while the smallest revenue quarter was Q4 2021 when SONN reported NA in revenue.

Any self directed investor doing their due diligence on SONN or any other given stock can benefit from researching all of the Sonnet BioTherapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Sonnet BioTherapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SONN. Thanks for visiting, and the next time you need to research SONN past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: BTE shares outstanding history, FRBK Historical PE Ratio, Top Ten Hedge Funds Holding FSBK.


SONN Past Earnings | | Copyright © 2020 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.